Publications
(last updated 18-10-2011)
- Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2
- ICARDI L, LIEVENS S, MORI R, PIESSEVAUX J, DE CAUWER L, DE BOSSCHER K & TAVERNIER J
- source: FASEB J. 2011 Sep 28. [Epub ahead of print]
- Selection of non-competitive leptin antagonists using a random nanobody-based approach
- ZABEAU L, VERHEE A, CATTEEUW D, FAES L, SEEUWS S, DECRUY T, ELEWAUT D, PEELMAN F & TAVERNIER J
- source: Biochem J. 2011 Aug 19. [Epub ahead of print]
- MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCV
- VAN SCHOUBROECK B, VAN ACKER K, DAMS G, JOCHMANS D, CLAYTON R, BERKE JM, LIEVENS S, VAN DER HEYDEN J & TAVERNIER J
- source: Methods Mol. Biol. in press
- Hypersensitive cytokine bioassays
- ZABEAU L, VAN DER HEYDEN J & TAVERNIER J
- source: Methods Mol. Biol. in press
- ArrayMAPPIT : a screening platform for human protein interactome analysis
- LIEVENS S, VANDERROOST N, DEFEVER D, VAN DER HEYDEN J & TAVERNIER J
- source: Methods Mol. Biol. in press
- HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in HCC cells
- ZHAO P, ZHANG W, WANG SJ, YU XL, TANG J, HUANG W, LI Y, CUI HY, GUO YS, TAVERNIER J, ZHANG SH, JIANG JL & CHEN ZN
- source: Hepatology. 2011 Aug 1. doi: 10.1002/hep.24592. [Epub ahead of print]
- Protein Engineering Approach Differentiates Functional Importance of Carbohydrate Moieties of Interleukin-5 Receptor α
- ISHINO T, ECONOMOU NJ, MCFADDEN K, ZAKS-ZILBERMAN M, JOST M, BAXTER S, CONTARINO MR, HARRINGTON AE, LOLL PJ, PASUT G, LIEVENS S, TAVERNIER J & CHAIKEN IM
- source: Biochemistry. 50, 7546-7556 (2011)
- Leptin receptor signaling: pathways to leptin resistance
- WAUMAN J & TAVERNIER J
- source: Front Biosci. 17, 2771-2793 (2011)
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- DELAHAYE NF, RUSAKIEWICZ S, MARTINS I, MÉNARD C, ROUX S, LYONNET L, PAUL P, SARABI M, CHAPUT N, SEMERARO M, MINARD-COLIN V, POIRIER-COLAME V, CHABA K, FLAMENT C, BAUD V, AUTHIER H, KERDINE-RÖMER S, PALLARDY M, CREMER I, PEAUDECERF L, ROCHA B, VALTEAU-COUANET D, GUTIERREZ JC, NUNÈS JA, COMMO F, BONVALOT S, IBRAHIM N, TERRIER P, OPOLON P, BOTTINO C, MORETTA A, TAVERNIER J, RIHET P, COINDRE JM, BLAY JY, ISAMBERT N, EMILE JF, VIVIER E, LECESNE A, KROEMER G & ZITVOGEL L
- source: Nat Med. 17, 700-707 (2011)
- CD248 facilitates tumor growth via its cytoplasmic domain
- MAIA M, DEVRIESE A, JANSSENS T, MOONS M, LORIES RJ, TAVERNIER J & CONWAY EM
- source: BMC Cancer. 11,162 (2011)
